The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Leuchten's Stock Ratings
UBS Analyst
Michael Leuchten is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/24/2025
Overall Average Return
9.72%
Smart Score
Overall Average Return Percentile
60th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/28/2022 | NVO | Buy Now | Novo Nordisk | $67.30 | — | Michael Leuchten58% | — | Downgrade | Neutral → Sell | Get Alert |
| 02/25/2021 | AZN | Buy Now | AstraZeneca | $70.83 | — | Michael Leuchten58% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/18/2019 | NVO | Buy Now | Novo Nordisk | $67.30 | — | Michael Leuchten58% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/02/2019 | AZN | Buy Now | AstraZeneca | $70.83 | — | Michael Leuchten58% | — | Downgrade | Neutral → Sell | Get Alert |
| 01/23/2018 | SNY | Buy Now | Sanofi | $51.29 | — | Michael Leuchten58% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 12/06/2016 | NVO | Buy Now | Novo Nordisk | $67.30 | — | Michael Leuchten58% | — | Upgrade | Sell → Buy | Get Alert |
| 02/08/2016 | NVO | Buy Now | Novo Nordisk | $67.30 | — | Michael Leuchten58% | — | Downgrade | Neutral → Sell | Get Alert |
| 01/09/2014 | AZN | Buy Now | AstraZeneca | $70.83 | — | Michael Leuchten58% | — | Initiates | → Buy | Get Alert |
| 11/04/2013 | AZN | Buy Now | AstraZeneca | $70.83 | — | Michael Leuchten58% | — | Downgrade | Buy → Neutral | Get Alert |
